Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Generix Group stock

GENX.PA
FR0010501692
A0MYAC

Price

9.70
Today +/-
+0
Today %
+0 %
P

Generix Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Generix Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Generix Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Generix Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Generix Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Generix Group Stock Price History

DateGenerix Group Price
9/12/20229.70 undefined
9/9/20229.70 undefined

Generix Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Generix Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Generix Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Generix Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Generix Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Generix Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Generix Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Generix Group’s growth potential.

Generix Group Revenue, EBIT and net profit per share

DateGenerix Group RevenueGenerix Group EBITGenerix Group Net Income
2026e99.75 M undefined8.64 M undefined4.23 M undefined
2025e98.66 M undefined8.31 M undefined4.27 M undefined
2024e97.92 M undefined8.16 M undefined4.39 M undefined
2023e91.8 M undefined6.12 M undefined3.47 M undefined
202284.5 M undefined6.25 M undefined3.41 M undefined
202180.26 M undefined7.11 M undefined4.22 M undefined
202081.1 M undefined9.47 M undefined3.41 M undefined
201976.64 M undefined5.31 M undefined2.29 M undefined
201870.29 M undefined2.16 M undefined565,000 undefined
201763 M undefined1.47 M undefined-181,000 undefined
201658.39 M undefined2.29 M undefined1.24 M undefined
201553.67 M undefined3.28 M undefined843,000 undefined
201449.4 M undefined3.54 M undefined3.7 M undefined
201363.13 M undefined3.13 M undefined1.63 M undefined
201264.27 M undefined-870,000 undefined-2.11 M undefined
201166.2 M undefined-5.2 M undefined-5.7 M undefined
201068.57 M undefined-3.47 M undefined-2.76 M undefined
200967.62 M undefined-5.22 M undefined-3.68 M undefined
200855.54 M undefined3.12 M undefined1.42 M undefined
20076.42 M undefined410,000 undefined300,000 undefined
200623.52 M undefined1.7 M undefined2.58 M undefined
200519.42 M undefined-660,000 undefined90,000 undefined
200416.2 M undefined-3.3 M undefined-3.28 M undefined
200317.27 M undefined-3.01 M undefined-1.75 M undefined

Generix Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023e2024e2025e2026e
121214201617161923655676866646349535863707681808491979899
--16.6742.86-20.006.25-5.8818.7521.05-73.91816.6721.821.49-2.94-3.03-1.56-22.228.169.438.6211.118.576.58-1.235.008.336.591.031.02
66.6775.0071.4375.0075.0076.4768.7578.9578.2666.6774.5570.1570.5968.1870.3174.6075.5175.4765.5265.0867.1469.7477.7882.5084.5278.0273.2072.4571.72
891015121311151844147484545473740384147536366710000
0-1-10-7-1-30201-3-2-5-213010023433444
------85.71200.00-----400.00-33.33150.00-60.00-150.00200.00-----50.0033.33-25.00-33.33--
2.672.672.672.672.672.675.6710.2810.2814.0215.3615.4115.4715.3721.1327.1825.5328.120.6722.1718.8325.4127.0727.1427.210000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Generix Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Generix Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
                                                 
0.50.10.10.30.10.3023.37.19.26.75.83.79.27.46.9405.56.946.789.2212.5214.5115.52
7.99.110.110.412.213.411.612.61321.321.630.624.519.918.726.533.1031.733.134.3829.4428.5827.1228.32
0.30.60.62.22.3111.71.109.53.94.45.47.95.5000009.0410.9611.8212.77
0000000000000200001000101211316
00000.10.20.20.30.6000000018.8800000000
8.79.810.812.914.714.912.816.61828.440.341.234.729.235.839.458.93037.240.0441.1747.752.0653.4556.62
0.10.10.20.20.20.20.20.30.41.12.52.32.31.91.113.3202.13.323.193.0811.6812.0610.39
0.10.10.20.10.10.10.10.20.21.710.70.60.50.50.50.5100.70.510.520.510.570.610.6
0000000000000000000000000
1.222.82.93.33.13.25.85.53.115.914.411.98.46.64.86.9303.66.935.44.444.95.827.98
00000000034.742.642.642.642.642.642.638.72034.738.7238.3138.5238.3741.9642.21
0.20.20.20.30.300004.501.93.64.54.84.73.9604.73.965.124.81.31.552.27
1.62.43.43.53.93.43.56.36.145.16261.96157.955.653.653.44045.853.4452.5451.3556.8262.0163.45
10.312.214.216.418.618.316.322.924.173.5102.3103.195.787.191.493112.3608393.4893.7199.05108.88115.46120.07
                                                 
1.51.51.81.82.33.22.64.34.76.57.17.27.27.212.912.911.08011.111.0811.0811.0811.1911.3211.35
2.52.55.15.14.7002.23.122.92828.128.12830.230.223.9902423.9923.9924.8425.3225.1925.16
0.6-1-2.8-2.8-7.6-2.8-2.9-2.8-0.28.67.74.21.7-3.8-5.8-4.50.3600.60.36-0.710.612.986.998.15
0000000000000000-0.550000-0.160.320.91.5
0000000000000000000000000
4.634.14.1-0.60.4-0.33.77.63842.839.53731.437.338.634.89035.735.4334.3636.3839.844.446.16
1.11.42.3332.42.83.22.915.521.524.123.4232121.122.69020.922.6923.1123.336.956.016.25
000000000000000000000014.4716.0417.39
4.14.96.27.710.513.112.612.112.711.718.321.221.321.820.819.614.61015.114.6114.8617.5218.6619.0722.62
0.10.6000.11.101.20.100000000.01000.010.550.01000
0.110.91.40.50.60.500.23.24.597.32.457.25.4905.25.495.357.967.8110.1711.35
5.47.99.412.114.117.215.916.515.930.444.354.35247.246.847.942.8041.242.843.8648.8347.8951.2857.61
00.90.400001.703.6136.545.74.21.57.6602.67.668.079.0417.0915.211.35
000000000300000000000000000
0.20.30.30.45.20.60.71.10.61.12.12.82.42.52.84.83.7903.23.794.34.593.864.213.91
0.21.20.70.45.20.60.72.80.6515.19.36.48.276.311.4505.811.4512.3713.6320.9519.4115.25
5.69.110.112.519.317.816.619.316.535.459.463.658.455.453.854.254.2504754.2556.2362.4568.8470.6972.87
10.212.114.216.618.718.216.32324.173.4102.2103.195.486.891.192.889.13082.789.6890.5998.84108.64115.1119.02
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Generix Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Generix Group's financial health and stability.

Assets

Generix Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Generix Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Generix Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Generix Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-1-10-7-1-30201-3-2-5-21411012354
111312210356632100233444
0000000001-1-1000-1000-10300
000400-1002242-3-400-11-1-1-113
0000000000000001,000-5,0000000000
000000000000000000000000
000000000000000000000000
0010000429363-204-30425101112
-1-2-2-2-1-2-2-20-1-1-1-10000-2-2-1-1-2-1-1
-1-2-2-2-1-2-2-2-3-13-3-3-1-10-110-3-8-2-5-3-7-6
00000000-3-12-2-10-10010-1-6-1-4-1-5-5
000000000000000000000000
1000000056-1-4-310-110503-3-1-4
0203221100000700-70000000
1202222056-1-4-390-2-70503-3-2-5
0000001,000-1,0000000000000000-1,0000-1,000
000000000000000000000000
0000001242-20-25-100-2102310
-2.06-2.2-0.19-2.17-2.66-2.74-1.042.271.988.41.865.032.05-2.47-0.674.04-3.65-1.682.21.583.918.099.5511.08
000000000000000000000000

Generix Group stock margins

The Generix Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Generix Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Generix Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Generix Group's sales revenue. A higher gross margin percentage indicates that the Generix Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Generix Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Generix Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Generix Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Generix Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Generix Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Generix Group Margin History

Generix Group Gross marginGenerix Group Profit marginGenerix Group EBIT marginGenerix Group Profit margin
2026e84.82 %8.66 %4.24 %
2025e84.82 %8.43 %4.33 %
2024e84.82 %8.33 %4.49 %
2023e84.82 %6.67 %3.78 %
202284.82 %7.39 %4.04 %
202182.96 %8.86 %5.26 %
202077.85 %11.67 %4.2 %
201969.42 %6.93 %2.98 %
201867.75 %3.08 %0.8 %
201765.58 %2.33 %-0.29 %
201665.57 %3.92 %2.12 %
201574.72 %6.11 %1.57 %
201475.65 %7.17 %7.49 %
201375.56 %4.96 %2.58 %
201270.78 %-1.35 %-3.28 %
201167.98 %-7.85 %-8.61 %
201070.23 %-5.06 %-4.03 %
200970.51 %-7.72 %-5.44 %
200875.14 %5.62 %2.56 %
200768.38 %6.39 %4.67 %
200679.8 %7.23 %10.97 %
200579.15 %-3.4 %0.46 %
200473.21 %-20.37 %-20.25 %
200376.43 %-17.43 %-10.13 %

Generix Group Stock Sales Revenue, EBIT, Earnings per Share

The Generix Group earnings per share therefore indicates how much revenue Generix Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Generix Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Generix Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Generix Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Generix Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Generix Group Revenue, EBIT and net profit per share

DateGenerix Group Sales per ShareGenerix Group EBIT per shareGenerix Group Earnings per Share
2026e4.4 undefined0 undefined0.19 undefined
2025e4.35 undefined0 undefined0.19 undefined
2024e4.32 undefined0 undefined0.19 undefined
2023e4.05 undefined0 undefined0.15 undefined
20223.11 undefined0.23 undefined0.13 undefined
20212.96 undefined0.26 undefined0.16 undefined
20203 undefined0.35 undefined0.13 undefined
20193.02 undefined0.21 undefined0.09 undefined
20183.73 undefined0.11 undefined0.03 undefined
20172.84 undefined0.07 undefined-0.01 undefined
20162.83 undefined0.11 undefined0.06 undefined
20151.91 undefined0.12 undefined0.03 undefined
20141.93 undefined0.14 undefined0.14 undefined
20132.32 undefined0.12 undefined0.06 undefined
20123.04 undefined-0.04 undefined-0.1 undefined
20114.31 undefined-0.34 undefined-0.37 undefined
20104.43 undefined-0.22 undefined-0.18 undefined
20094.39 undefined-0.34 undefined-0.24 undefined
20083.62 undefined0.2 undefined0.09 undefined
20070.46 undefined0.03 undefined0.02 undefined
20062.29 undefined0.17 undefined0.25 undefined
20051.89 undefined-0.06 undefined0.01 undefined
20042.86 undefined-0.58 undefined-0.58 undefined
20036.47 undefined-1.13 undefined-0.66 undefined

Generix Group business model

Generix Group SA is a leading provider of software solutions for supply chain management and e-commerce. The company was founded in 1990 in France and has its headquarters in Paris. It employs over 1,000 employees and operates in Europe, North America, and Asia. Its business model is based on the development and sale of software solutions for optimizing supply chains and business processes. They offer a range of products including warehouse management systems, transport management systems, supply chain planning, electronic data interchange, and e-commerce platforms. The company is segmented into three business areas: supply chain collaboration, supply chain execution, and e-commerce. They offer solutions for collaboration between suppliers, customers, and partners, as well as inventory management, transportation, and delivery management. They also have platforms for online sales and distribution that cater to B2B and B2C companies. Some of their key products include collaborative supply chain management, warehouse management, and transportation management. They also develop innovative technologies such as robotic warehouses and cloud platforms for e-commerce. They are pioneers in artificial intelligence and machine learning, working closely with universities and research institutions. Overall, Generix Group SA has a strong position in the supply chain management and e-commerce solutions market, offering a wide range of products tailored to various industries. With their focus on innovation and technology, they are well positioned for future success. Generix Group is one of the most popular companies on Eulerpool.com.

Generix Group SWOT Analysis

Strengths

Generix Group SA possesses several strengths that contribute to its success in the market. These include:

  • Strong Market Presence: Generix Group SA has established a solid presence in the industry, with a wide customer base and a reputable brand.
  • Product Innovation: The company is known for its continuous investment in research and development, resulting in innovative and cutting-edge solutions.
  • Skilled Workforce: Generix Group SA has a highly skilled and experienced workforce that enables efficient operations and effective customer support.
  • Global Footprint: With an international presence, Generix Group SA has the opportunity to tap into diverse markets and expand its reach.

Weaknesses

Despite its strengths, Generix Group SA also has several weaknesses that may hinder its growth and competitiveness. These include:

  • Dependency on Key Customers: The company relies heavily on a few major clients, which creates vulnerability in case of loss or dissatisfaction of these customers.
  • Limited Product Portfolio: Generix Group SA's product offerings are primarily focused on specific segments, limiting its ability to cater to a broader range of industries and customer needs.
  • High Reliance on Technology: The company heavily relies on technology for its solutions, making it susceptible to disruptions or technological advancements that may render its products obsolete.
  • Competitive Market: Generix Group SA faces intense competition from other industry players, which may impact its market share and profitability.

Opportunities

Generix Group SA has identified several opportunities that can be leveraged to its advantage. These include:

  • Emerging Markets: Expansion into emerging markets presents significant growth opportunities for Generix Group SA, where demand for its solutions may be high.
  • Digital Transformation: The increasing need for digital transformation in various industries provides a chance for Generix Group SA to offer its innovative solutions to companies seeking to modernize their operations.
  • Partnerships and Collaborations: The company can form strategic partnerships and collaborations with other organizations to expand its product offerings, access new markets, and enhance its competitive position.
  • Trends in Supply Chain Management: The evolving trends in supply chain management, such as e-commerce and omnichannel retailing, create opportunities for Generix Group SA to develop tailored solutions to meet changing customer demands.

Threats

Alongside opportunities, Generix Group SA also faces certain threats that may impact its business negatively. These threats include:

  • Changing Regulatory Environment: Compliance with evolving regulations and policies can pose challenges for Generix Group SA, requiring constant monitoring and adaptation.
  • Economic Instability: Economic downturns or recessions in key markets may impact customer spending and reduce demand for the company's solutions.
  • New Entrants and Competitors: The entrance of new competitors or the expansion of existing competitors' offerings may intensify competition and potentially erode Generix Group SA's market share.
  • Rapid Technological Changes: The rapid pace of technological advancements requires Generix Group SA to continually invest in research and development to stay ahead of competitors and meet customer expectations.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Generix Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Generix Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Generix Group shares outstanding

The number of shares was Generix Group in 2023 — This indicates how many shares 27.214 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Generix Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Generix Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Generix Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Generix Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Generix Group stock splits

In Generix Group's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Generix Group.

Generix Group shareholders

%
Name
Stocks
Change
Date
55.58542 % Pléiade Investissement12,605,2492,977,9426/10/2022
5.64613 % Montefiore Investment1,280,38706/10/2022
3.56140 % Deconninck Family807,62806/10/2022
2.20485 % Financière Arbevel500,000-40,0003/31/2022
1.37742 % Gay-Lussac Gestion SAS312,36205/31/2022
1.07563 % CPR Asset Management243,92405/31/2022
1.06193 % Barma (Jean-Luc)240,816240,8167/8/2022
0.95842 % Collette Sene (Aida)217,34406/10/2022
0.90948 % Seguin (Philippe)206,24406/10/2022
0.79123 % Sycomore Asset Management179,43002/28/2022
1
2
3
4

Generix Group Executives and Management Board

Mr. Jean-Charles Deconninck(62)
Generix Group Chairman of the Management Board
Compensation 396,016
Mrs. Aida Collette-Sene
Generix Group Chief Executive Officer, Managing Director, Member of the Management Board
Compensation 332,159
Mr. Ludovic Luzza(43)
Generix Group Group Administrative and Financial Director, Member of the Management Board
Compensation 174,791
Mr. Francois Poirier(62)
Generix Group Chairman of the Supervisory Board (since 2002)
Compensation 10,000
Mr. Dominique Despiney(70)
Generix Group Independent Vice Chairman of the Supervisory Board
Compensation 10,000
1
2

Most common questions regarding Generix Group

What values and corporate philosophy does Generix Group represent?

Generix Group SA is a leading company that values innovation, dedication, and customer satisfaction. With a strong corporate philosophy, Generix Group SA focuses on delivering cutting-edge technology solutions for supply chain management and digital transformation. The company aims to provide reliable and efficient services tailored to meet the unique needs of its clients. Generix Group SA remains committed to enabling businesses to adapt to the evolving market trends and enhance their operational processes. By leveraging its extensive expertise and forward-thinking approach, Generix Group SA continues to empower organizations to achieve their full potential in the constantly changing business landscape.

In which countries and regions is Generix Group primarily present?

Generix Group SA is primarily present in a wide range of countries and regions. With its global presence, the company operates in numerous countries including France, Spain, Belgium, Canada, Brazil, Mexico, and Morocco among others. As a leading international software provider, Generix Group SA continues to expand its footprint worldwide, serving clients across various industries. Through its innovative solutions, Generix Group SA aims to support businesses in optimizing their supply chain and logistics operations efficiently.

What significant milestones has the company Generix Group achieved?

Generix Group SA, a leading provider of collaborative SaaS solutions to optimize supply chain processes, has achieved significant milestones. Over the years, the company has demonstrated remarkable growth and innovation in the field of supply chain management. Generix Group SA has successfully expanded its global presence, establishing subsidiaries and partnerships worldwide. By continuously improving its software solutions, the company has enabled businesses to enhance efficiency, reduce costs, and streamline their supply chain operations. Innovations such as their Supply Chain Hub and Click&Collect solutions have solidified Generix Group SA's position as a trusted partner for businesses seeking advanced supply chain optimization.

What is the history and background of the company Generix Group?

Generix Group SA is a renowned company with a rich history and background. Founded in 1990, Generix Group SA is a leading provider of collaborative SaaS solutions for the supply chain ecosystem. The company specializes in optimizing and streamlining supply chain operations for businesses of all sizes. Generix Group SA has successfully expanded its reach internationally and now operates in more than 60 countries. With a strong focus on innovation, the company continuously develops cutting-edge technologies to meet the evolving needs of its clients. Generix Group SA's commitment to excellence and its extensive industry experience make it a trusted partner in the supply chain management sector.

Who are the main competitors of Generix Group in the market?

The main competitors of Generix Group SA in the market include companies like SAP SE, Oracle Corporation, IBM Corporation, and Infor, among others.

In which industries is Generix Group primarily active?

Generix Group SA is primarily active in the software and technology industry.

What is the business model of Generix Group?

Generix Group SA is a leading provider of collaborative business solutions for supply chain management. Their business model revolves around offering a wide range of software products and services to optimize and streamline supply chain operations. By leveraging innovative technologies, Generix Group SA assists companies in enhancing their logistics, warehouse management, transportation, and e-commerce processes. Additionally, they provide value-added services, such as data analytics and business intelligence, to help businesses make informed decisions and improve overall efficiency. Generix Group SA aims to empower organizations across various industries by delivering tailored solutions that drive operational excellence and foster growth.

What is the P/E ratio of Generix Group 2024?

The Generix Group P/E ratio is 60.06.

What is the P/S ratio of Generix Group 2024?

The Generix Group P/S ratio is 2.7.

What is the Quality Investing of Generix Group?

The Quality Investing for Generix Group is 3/10.

What is the revenue of Generix Group 2024?

The expected Generix Group revenue is 97.92 M EUR.

How high is the profit of Generix Group 2024?

The expected Generix Group profit is 4.39 M EUR.

What is the business model of Generix Group

The Generix Group SA is a leading provider of business software solutions for companies around the world. With a wide range of products and services in various industries, the company offers comprehensive services for planning, implementation, and optimization of your business processes. The company is divided into four business units: Supply Chain Management (SCM), SaaS Cloud Services, Digital Transformation, and Enterprise Resource Planning (ERP). SCM is one of the most important units of Generix, offering solutions for production, distribution, and logistics. The SaaS Cloud Unit provides companies with the opportunity to manage their business processes in a secure and reliable cloud environment. The Digital Transformation Unit focuses on implementing technologies such as AI, blockchain, and IoT to improve business processes. ERP is one of the most well-known business units, providing comprehensive management solutions. Generix also offers a mobile app solution for supply chain management processes. The company collaborates with partners such as Oracle, Salesforce, and Microsoft to create customized systems for improved customer satisfaction. In summary, Generix Group SA is a leading provider of business software solutions, offering comprehensive services for planning, implementation, and optimization of business processes. The company's main areas of focus include SCM, SaaS Cloud Services, Digital Transformation, and ERP. With a focus on innovation and customer satisfaction, Generix Group SA will continue to play an important role in the global technology market.

What is the Generix Group dividend?

Generix Group pays a dividend of 0 EUR distributed over payouts per year.

How often does Generix Group pay dividends?

The dividend cannot currently be calculated for Generix Group or the company does not pay out a dividend.

What is the Generix Group ISIN?

The ISIN of Generix Group is FR0010501692.

What is the Generix Group WKN?

The WKN of Generix Group is A0MYAC.

What is the Generix Group ticker?

The ticker of Generix Group is GENX.PA.

How much dividend does Generix Group pay?

Over the past 12 months, Generix Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Generix Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Generix Group?

The current dividend yield of Generix Group is .

When does Generix Group pay dividends?

Generix Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Generix Group?

Generix Group paid dividends every year for the past 0 years.

What is the dividend of Generix Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Generix Group located?

Generix Group is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Generix Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Generix Group from 11/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Generix Group pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Generix Group in the year 2023?

In the year 2023, Generix Group distributed 0 EUR as dividends.

In which currency does Generix Group pay out the dividend?

The dividends of Generix Group are distributed in EUR.

All fundamentals about Generix Group

Our stock analysis for Generix Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Generix Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.